Search research articles
Contact Us
Filters
Showing results (91-100 of 418) with videos related to
Page
of 42
Sort By:
The Lancet. Oncology
|
February 23, 2010
Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care
Debashish Bose, Funda Meric-Bernstam, Wayne Hofstetter, et al.
Journal of the National Cancer Institute
|
February 11, 2014
Genetic alterations and personalized medicine in melanoma: progress and future prospects
Klaus G Griewank, Richard A Scolyer, John F Thompson, et al.
Cancer Chemotherapy and Pharmacology
|
May 8, 2004
A phase I, dose escalation trial of ZD0473, a novel platinum analogue, in combination with gemcitabine
Keith T Flaherty, James P Stevenson, Maryann Redlinger, et al.
The Journal of Investigative Dermatology
|
August 25, 2015
BRAF Inhibition Generates a Host-Tumor Niche that Mediates Therapeutic Escape
Inna V Fedorenko, Jennifer A Wargo, Keith T Flaherty, et al.
Molecular Cancer Therapeutics
|
May 30, 2006
Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases
Keiran S M Smalley, Nikolas K Haass, Patricia A Brafford, et al.
Cancer Chemotherapy and Pharmacology
|
February 26, 2011
Interaction of sorafenib and cytochrome P450 isoenzymes in patients with advanced melanoma: a phase I/II pharmacokinetic interaction study
Keith T Flaherty, Chetan Lathia, Reginald F Frye, et al.
Plos One
|
April 12, 2011
A melanoma molecular disease model
Smruti J Vidwans, Keith T Flaherty, David E Fisher, et al.
Cancer Discovery
|
July 22, 2021
Rethinking Cancer Clinical Trial Conduct Induced by COVID-19: An Academic Center, Industry, Government, and Regulatory Agency Perspective
Keith T Flaherty, James H Doroshow, Susan Galbraith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 7, 2011
New challenges in endpoints for drug development in advanced melanoma
Antoni Ribas, Peter Hersey, Mark R Middleton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2006
Mechanisms of hypertension associated with BAY 43-9006
Maria Luisa Veronese, Ari Mosenkis, Keith T Flaherty, et al.
Page
of 42
Search research articles
Search
Showing results (91-100 of 418) with videos related to
Sort By:
Page
of 42
The Lancet. Oncology
|
February 23, 2010
Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care
Debashish Bose, Funda Meric-Bernstam, Wayne Hofstetter, et al.
Journal of the National Cancer Institute
|
February 11, 2014
Genetic alterations and personalized medicine in melanoma: progress and future prospects
Klaus G Griewank, Richard A Scolyer, John F Thompson, et al.
Cancer Chemotherapy and Pharmacology
|
May 8, 2004
A phase I, dose escalation trial of ZD0473, a novel platinum analogue, in combination with gemcitabine
Keith T Flaherty, James P Stevenson, Maryann Redlinger, et al.
The Journal of Investigative Dermatology
|
August 25, 2015
BRAF Inhibition Generates a Host-Tumor Niche that Mediates Therapeutic Escape
Inna V Fedorenko, Jennifer A Wargo, Keith T Flaherty, et al.
Molecular Cancer Therapeutics
|
May 30, 2006
Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases
Keiran S M Smalley, Nikolas K Haass, Patricia A Brafford, et al.
Cancer Chemotherapy and Pharmacology
|
February 26, 2011
Interaction of sorafenib and cytochrome P450 isoenzymes in patients with advanced melanoma: a phase I/II pharmacokinetic interaction study
Keith T Flaherty, Chetan Lathia, Reginald F Frye, et al.
Plos One
|
April 12, 2011
A melanoma molecular disease model
Smruti J Vidwans, Keith T Flaherty, David E Fisher, et al.
Cancer Discovery
|
July 22, 2021
Rethinking Cancer Clinical Trial Conduct Induced by COVID-19: An Academic Center, Industry, Government, and Regulatory Agency Perspective
Keith T Flaherty, James H Doroshow, Susan Galbraith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 7, 2011
New challenges in endpoints for drug development in advanced melanoma
Antoni Ribas, Peter Hersey, Mark R Middleton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2006
Mechanisms of hypertension associated with BAY 43-9006
Maria Luisa Veronese, Ari Mosenkis, Keith T Flaherty, et al.
Page
of 42